Acknowledgements:

Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904)

ADNI is funded by:

National Institute on Aging
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering


and through generous contributions from the following:

Abbott
AstraZeneca AB
Bayer Schering Pharma AG
Merck & Co., Inc.
AstraZeneca AB
Bayer Schering Pharma AG
 Bristol-Myers Squibb
Eisai Global Clinical Development
Elan Corporation
Genentech
GE Healthcare
GlaxoSmithKline
Innogenetics
Johnson and Johnson
Eli Lilly and Co.
Medpace, Inc.
Merck and Co., Inc
Novartis AG
Phizer Inc
Hoffman-La Roche
Schering-Plough
Synarc, Inc.
Wyeth

As Well as non-profit partners in:
the Alzheimer's Association
the Alzheimer's Drug Discovery Foundation

with participation from:
U.S. Food and Drug Administration

Private sector contributions to ADNI are facilitated by: 
The Foundation for the National Institutes of Health
www.fnih.org

The grantee organization is:
The Northern California Institute for Research and Education

Coordinated by:
Alzheimer’s Disease Cooperative Study at the University of California, San Diego

ADNI data are disseminated by the Laboratory for Neuro Imaging at the University
of California, Los Angeles. This research was also supported by NIH grants
P30 AG010129, K01 AG030514, and the Dana Foundation.